The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

A COVID-19 strain with the nickname of "nimbus" has become the dominant variant of that disease in the U.S. but hasn't yet ...

Disaster Recovery-as-a-Service Market Rising cyber-attacks, blackouts, and demand for data protection and recovery fuel growth in the globa ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

Scientists sometimes compare predicting the course of epidemics to forecasting the weather. But there's a major difference—the impact of human behavior—says Alessandro Vespignani, director of ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

The Business Research Company's The Specific Antiviral Drugs For COVID 19 Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams It will grow to $28.43 billion in 2029 at a ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines. Newly released documents show the FDA’s vaccine chief, ...

The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat ...